Prolight Diagnostics AB (publ) (NGM:PRLD)

Market Cap	243.12M
Revenue (ttm)	34.60M
Net Income (ttm)	-30.46M
Shares Out	1.20B
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,882,965
Average Volume	3,967,790
Open	n/a
Previous Close	0.2000
Day's Range	n/a
52-Week Range	0.1181 - 0.8092
Beta	3.27
RSI	53.24
Earnings Date	Nov 28, 2025

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing systems in Sweden. The company offers Psyros, for measurement of biomarkers at extremely low concentrations; and MicroFlex, a point of care system to test with a small disposable cartridge. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 21
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2024, Prolight Diagnostics AB's revenue was 36.33 million, an increase of 50.02% compared to the previous year's 24.22 million. Losses were -26.94 million, -80.11% less than in 2023.